- Atlas
- Natural Sciences
- Biomaterials
Biomaterials
Biomaterials are materials designed to sit inside or against the living body and do a job there: replace a hip joint, hold a wound closed, scaffold new tissue, deliver a drug, or quietly disappear once the body has healed.
9 frameworks, from 1940 to today · Materials Science · Natural Sciences
- Inert biomaterials 1940-1980
- Protein adsorption 1965-Present
- Retrieval and failure analysis 1970-1995
- Synthetic biodegradable polymer 1970-Present
- Bioactive materials 1971-Present
- Tissue engineering 1988-Present
- Additive manufacturing of biomaterials 2000-Present
- Biodegradable metals 2000-Present
- Immunomodulatory biomaterials 2010-Present
Overview
Biomaterials are materials designed to sit inside or against the living body and do a job there: replace a hip joint, hold a wound closed, scaffold new tissue, deliver a drug, or quietly disappear once the body has healed1. The field sits where materials science meets medicine, and its central problem is unlike almost any other in engineering1. A bridge girder must resist weather; an implant must resist a body that is actively trying to dissolve, encapsulate, or reject it, while the body itself must not be poisoned or chronically inflamed by the material. What makes the history interesting is that the definition of success kept shifting. Early practitioners asked whether a material could survive the body without doing harm. Later ones asked whether the body could be persuaded to accept, or even rebuild itself around, the material. Today many ask whether the material can steer the immune system deliberately. Each shift came from a failure the previous approach could not explain.
Metals, Sutures, and the First Implants
Repairing the body with foreign materials is ancient. Archaeological finds include gold dental wire and, from roughly the first millennium BCE, sutures of linen, hair, and gut; the Roman writer Galen described gladiators' tendon repairs. But the modern field begins with the industrial production of metals and sterile surgery in the nineteenth and early twentieth centuries. Bone plates of iron and later steel were tried for fractures in the late 1800s, often failing through corrosion and infection. The decisive material was stainless steel: the "18-8" austenitic alloy (roughly 18% chromium, 8% nickel) developed in Germany before the First World War, and its surgical variant, which came to be known as 316L, became the workhorse of orthopaedics. Its chromium-rich surface oxide layer, a few atoms thick, passivates the metal—seals it against further reaction—so it corrodes only slowly in body fluid2.
The mid-twentieth century brought the era now called inert biomaterials: substances chosen to provoke as little reaction as possible. Titanium and its alloys, whose oxide layer makes them unusually well tolerated by bone, entered orthopaedics in the 1940s and 1950s; the polymethyl methacrylate bone cement used to fix hip implants was adapted from dentistry in the late 1950s, and the total hip replacement pioneered by John Charnley in England around 1962 combined a stainless-steel stem, a polyethylene socket, and acrylic cement into a procedure that transformed millions of lives. The guiding belief was "minimal interaction": the best material is one the body ignores. That belief was productive but incomplete, and the failures it produced drove the next phase.
Retrieval and the Anatomy of Failure
Implants that seemed fine in the operating theatre sometimes loosened, discoloured, or killed the surrounding bone years later. The response was a discipline of retrieval and failure analysis: systematically recovering explanted devices and examining them with the tools of metallurgy and pathology. Work at institutions such as the Cleveland Clinic and later dedicated implant retrieval laboratories in the 1970s and 1980s showed that "inert" was a fiction. Metal ions leached; wear particles from polyethylene sockets triggered a foreign-body reaction in which immune cells called macrophages, frustrated at being unable to digest the particles, released signalling molecules that activated bone-resorbing cells (osteoclasts), loosening the implant—a process known as particle disease or osteolysis. Retrieval studies taught the field that the body's response, not just the material's bulk properties, determines whether a device lasts. This reframing set up everything that followed.
The Surface Is the Interface
If the body reacts to the material's surface rather than its interior, then surface science becomes central. When an implant enters the body, it is coated within seconds by a layer of adsorbed proteins from blood and tissue fluid—albumin, fibrinogen, immunoglobulins, and others—and cells actually "see" this protein film, not the bare material. Research from the 1960s onward, drawing on the physical chemistry of adsorption, established that the composition, charge, and wettability of a surface determine which proteins stick and in what conformation, and therefore whether platelets clump (clotting) or cells spread and adhere. A landmark concept from the 1980s, the Vroman effect, described how proteins compete for a surface over time, with abundant but weakly bound proteins displaced by scarcer ones with higher affinity. This understanding made surface modification a design tool: coatings, chemical grafts, and texturing to control protein adsorption and hence clotting, infection, and tissue integration.
Bioactive Materials: Making the Body Respond
The next turning point inverted the goal. Instead of hiding from the body, a material could chemically bond to it. The key discovery was Bioglass, a soda–lime–phosphosilicate glass developed by Larry Hench and colleagues at the University of Florida and reported in 1971. Implanted in bone, certain compositions of this glass dissolve slightly at the surface and precipitate a layer of hydroxycarbonate apatite—chemically close to bone mineral—which living bone then bonds to directly, without the fibrous scar capsule that forms around inert implants. The mechanism was a controlled surface reaction, and it showed that a synthetic material could be bioactive: provoke a specific, beneficial biological response. A parallel line of work produced calcium phosphate ceramics, notably hydroxyapatite, used as bone-graft substitutes from the 1970s and 1980s. Bioactive materials reframed the implant as a participant in healing rather than a passive guest.
Polymers That Dissolve: Sutures, Screws, and Drug Carriers
Meanwhile, a different class of materials was being developed: resorbable polymers, which break down in the body into harmless products and are eventually eliminated1. The best-known is poly(lactic-co-glycolic acid), or PLGA, a copolymer of lactic and glycolic acid whose degradation rate can be tuned by changing the ratio of the two components; it hydrolyses into lactic and glycolic acid, which enter normal metabolism. Absorbable sutures based on related polyesters (polyglycolic acid under the trade name Dexon, introduced in the early 1970s) removed the need for a second operation to take stitches out. The same chemistry became the backbone of controlled drug delivery: polymer microspheres and implants that release a drug slowly over weeks or months, an approach advanced by Robert Langer and Judah Folkman's work on macromolecule release in the mid-1970s and commercialised in products such as the leuprolide-releasing implant Lupron Depot in the late 1980s. Resorbable polymers made the implant temporary by design—a profound change in what a biomaterial could be.
Tissue Engineering and the Scaffold
By the 1980s the ambition grew larger: rather than replace tissue, regrow it. The term tissue engineering was formalised at a landmark 1988 meeting sponsored by the US National Science Foundation, and the field's founding statement is often dated to a 1993 paper by Langer and Joseph Vacanti in Science. The central object is the scaffold: a porous, often resorbable structure that mimics the extracellular matrix—the mesh of proteins and polysaccharides that holds cells in living tissue—providing mechanical support and physical cues while cells migrate in, multiply, and lay down their own matrix as the scaffold degrades13. Early successes included skin substitutes and cartilage constructs; a widely cited demonstration was the 1990s engineering of a functioning bladder by Anthony Atala's group, reported in 2006, in which patients' own cells were grown on a biodegradable scaffold. Scaffold design became a discipline in itself, balancing pore size (large enough for cells and blood vessels to penetrate), degradation rate (matched to the rate of new tissue formation), and stiffness.
Biodegradable Metals and the Corrosion That Heals
A newer twist on resorption concerns metals. Magnesium and its alloys corrode in the body, releasing magnesium ions the body handles routinely, and were tried as implant metals as early as the late nineteenth century—but too fast, producing hydrogen gas bubbles and losing strength before bone healed. Modern biodegradable metals research, accelerating from the 2000s, engineered alloys and coatings to slow corrosion to a useful rate, so that a magnesium screw can hold a fracture while it heals and then vanish, avoiding a removal operation. Iron and zinc alloys followed as alternatives with different corrosion profiles. The concept is elegant but demanding: the corrosion rate must be matched to healing, and the local chemistry of degradation must be benign.
Printing the Implant
Additive manufacturing—building objects layer by layer from a digital model—entered biomaterials from the 1990s and became transformative in the 2000s and 2010s. Techniques such as selective laser melting of titanium allowed implants with porous, bone-like lattice structures that encourage bone ingrowth and match a patient's anatomy from a CT scan; extrusion-based printing of polymers and hydrogels allowed scaffolds with precisely controlled pore architecture and even the printing of cells themselves (bioprinting). The method solved a problem conventional manufacturing could not: making complex, patient-specific, internally porous structures economically, and controlling scaffold geometry at the scale of cells.
Steering the Immune System
The most recent reframing grows directly from the retrieval lessons. The immune system is not merely an obstacle to be evaded; it is a participant that can be directed. Immunomodulatory biomaterials aim to shape the response—for instance, promoting a "pro-healing" macrophage state rather than the inflammatory one that causes fibrosis and implant rejection, or using materials as vaccine adjuvants or to induce tolerance. Research from the 2010s onward showed that physical and chemical properties of a material—its stiffness, its surface chemistry, the size and shape of its particles—can bias immune cells toward healing or inflammation. This closes a loop with the earliest retrieval studies: the field now designs deliberately for the biological response it once merely observed.
Where the Field Stands
Today biomaterials research runs along all these lines at once. Metals remain dominant in load-bearing orthopaedics, now often additively manufactured and surface-engineered; bioactive glasses and ceramics anchor bone regeneration; resorbable polyesters underpin sutures, drug delivery, and scaffolds; hydrogels—water-swollen polymer networks—dominate soft-tissue and cell-based work; and biodegradable metals are moving through clinical trials. The open questions are substantial: matching degradation to healing in every patient, achieving long-term integration without fibrosis, manufacturing patient-specific devices at acceptable cost, and understanding and controlling the immune response well enough to make "pro-healing" a reliable design specification rather than a laboratory observation. The history's pattern—each era defined by a failure the previous definition of success could not accommodate—suggests the field's ambitions will keep outrunning its materials.
References
- Biomaterial (introduction, Introduction, Biodegradable biomaterials, Skin repair), Wikipedia
- Stainless steel, Wikipedia
- Synthetic biodegradable polymer, Wikipedia
The frameworks of Biomaterials
Each framework is a way of working the field has used: when it held, and the question it answers.
- 1940-1980
- 1965-Present
- 1970-1995
- 1970-Present
Synthetic biodegradable polymer
How can a material dissolve safely in the body?
- 1971-Present
- 1988-Present
- 2000-Present
Additive manufacturing of biomaterials
How can we build implants layer by layer?
- 2000-Present
- 2010-Present
Immunomodulatory biomaterials
How can a material steer the immune response?
How the ideas connect
Each arrow runs from an earlier idea to the later one it shaped. The list below says what passed between them.
Retrieval and failure analysis influenced by Inert biomaterials
Retrieval and failure analysis arose directly from the clinical failures of inert implants: systematic examination of explanted devices showed that 'inert' materials provoked particle disease and osteolysis, reframing the body's response as central.
Carried by Cleveland Clinic; implant retrieval laboratories.
Bioactive materials reacted against Inert biomaterials
Bioactive materials defined themselves against the inert paradigm: instead of minimizing interaction, Bioglass was designed to react with body fluid and bond directly to bone, rejecting the goal of being ignored by the body.
Carried by Larry Hench; Bioglass.
Tissue engineering influenced by Synthetic biodegradable polymer
Tissue engineering adopted resorbable polymers as scaffold materials: the scaffold is a temporary structure that degrades as cells lay down new matrix, a concept made possible by synthetic biodegradable polymers.
Carried by Robert Langer; Joseph Vacanti.
Tissue engineering influenced by Bioactive materials
Bioactive materials demonstrated that a synthetic material could provoke a specific beneficial biological response; tissue engineering generalized this to scaffolds that actively direct cell behavior and tissue formation.
Immunomodulatory biomaterials influenced by Tissue engineering
Tissue engineering's focus on directing cell behavior led to the recognition that the immune system must be steered, not avoided; immunomodulatory biomaterials design scaffolds and surfaces to promote healing macrophages and reduce chronic inflammation.
Biodegradable metals influenced by Synthetic biodegradable polymer
The success of resorbable polymers established the principle of temporary implants that disappear after healing; biodegradable metals extended this to load-bearing applications where polymers were too weak.
Beyond the field
Where Biomaterials's ideas came from in other fields, and what they led to there: the strongest 12 of 29 links.
Bioactive materials reacted against Inert biomaterials paradigm in Biomaterials
Bioactive materials arose as a deliberate rejection of the inert biomaterials paradigm, which sought implants encapsulated by fibrous tissue rather than chemically bonded to bone. Hench designed 45S5 Bioglass specifically to bond to bone, defining the new class of surface-reactive materials against the inertness ideal.
Carried by Larry L. Hench.
Tissue engineering led to Decellularization in Tissue Engineering
Decellularized tissue matrices were adopted as natural scaffolds within tissue engineering, building on the field's scaffold-and-cell paradigm. The decellularization approach grew out of the tissue engineering community's search for biomimetic scaffold materials.
Carried by Stephen F. Badylak.
Biodegradable metals grew out of Resorbable and degradable materials paradigm in Biomaterials
Biodegradable metals grew directly out of the resorbable and degradable materials paradigm, extending the goal of temporary implants from polymers and ceramics to metallic alloys such as magnesium and iron. The same design principles, including degradation rate control and biocompatibility of degradation products, were carried over.
Carried by Resorbable and degradable materials paradigm (1965–today).
Inert biomaterials influenced Rigid Internal Fixation (AO Principles) in Oral And Maxillofacial Surgery
Inert biomaterials such as stainless steel and later titanium supplied the implant materials that made stable rigid internal fixation of bone feasible.
Inert biomaterials influenced by Amalgam and Cast-Metal Restorative Materials Programme in Restorative Dentistry
The inert biomaterials paradigm inherited its evaluation standards from dental amalgam and cast-metal restorations: corrosion resistance, minimal tissue reaction and long-term clinical service were the criteria dental materials science had already developed for metals in the mouth. Early implant surgeons and materials scientists drew directly on this dental experience when screening metals and polymers for inertness.
Inert biomaterials influenced AO internal fixation in Orthopedic Surgery
Inert biomaterials, especially stainless steel and later titanium alloys, made AO plates and screws possible without the corrosion and tissue reaction of earlier metals. The AO group specified corrosion-resistant implants drawing on mid-century materials science.
Inert biomaterials influenced Internal fixation in Veterinary Surgery
Inert metal biomaterials such as stainless steel and later titanium alloys made implantable plates and screws biologically tolerable, which was a precondition for modern internal fixation. The materials work carried the link.
Inert biomaterials influenced Osseointegration in Prosthodontics
Research on inert metallic biomaterials, especially titanium's corrosion resistance and lack of fibrous encapsulation, supplied the material concept Brånemark relied on when he interpreted bone anchorage as osseointegration.
Inert biomaterials influenced Artificial organ in Biomedical Engineering
Inert biomaterials provided the materials science, such as biocompatible polymers and metals, that made implantable and extracorporeal artificial organs feasible.
Inert biomaterials influenced Dental implant in Restorative Dentistry
The mid-century development of inert biomaterials, especially titanium and its biocompatibility, was the material basis for Brånemark's osseointegrated implants.
Carried by Per-Ingvar Brånemark.
Inert biomaterials influenced Bioceramic in Ceramic Materials
The inert biomaterials paradigm, with its requirement that implants not provoke reaction, shaped the first bioceramics such as alumina hip heads, which were chosen for chemical inertness.
Protein adsorption influenced by Adsorption Isotherm Models in Surface Chemistry
Protein adsorption research adopted the Langmuir, Freundlich and BET isotherm equations from surface chemistry to describe protein uptake as a function of bulk concentration, and later modified them for competitive and irreversible binding. The isotherm formalism remained the standard fitting method in biomaterials adsorption work.

Biomaterials is a planet in Nousfarer
Its city has a tower for each of these 9 frameworks. Land, walk in, and climb one concept at a time.
Land on BiomaterialsRelated fields
Fields its ideas are linked to
- Biomaterials 7 links
- Tissue Engineering 2 links
- Surface Chemistry 2 links
- Restorative Dentistry 2 links
- Composite Materials 2 links
- Structural Materials 2 links
- Immunology 2 links
- Biomedical Engineering 1 link
- Materials Chemistry 1 link
- Oral And Maxillofacial Surgery 1 link
- Prosthodontics 1 link
- Ceramic Materials 1 link
More in Materials Science
- Ceramic Materials
- Composite Materials
- Computational Materials Science
- Corrosion And Degradation
- Electronic And Magnetic Materials
- Energy Materials
- Materials Characterization
- Materials Processing
- Materials Science
- Materials Thermodynamics And Phase Transformations
- Mechanical Behavior Of Materials
- Metallurgy
- Nanomaterials
- Polymer Science
- Quantum Materials
- Semiconductor Materials
- Structural Materials